Chitin-chitosan: Properties, benefits and risks

被引:273
作者
Koide, SS [1 ]
机构
[1] Populat Council, Ctr Biomed Res, New York, NY 10021 USA
关键词
cholesterol; lipids; dietary fiber; vitamin E; calcium; growth retardation;
D O I
10.1016/S0271-5317(98)00091-8
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
A beneficial effect of chitin-chitosan as a food supplement is the reduction of plasma cholesterol and triglycerides due to its ability to bind dietary lipids, thereby reducing intestinal lipid absorption. The hypolipidemic influence of chitosan may also be due to interruption of the enterohepatic bile acid circulation. Plasma cholesterol in animals on cholesterol-free diet, however, is not affected, indicating that endogenous biosynthesis of cholesterol remains intact. Chitosan acts by forming gels in the intestinal tract which entrap lipids and other nutrients, including fat soluble vitamins and minerals, thus interfering with their absorption. Dietary chitosan may influence calcium metabolism by accelerating its urinary excretion. The reported undesirable effects are a marked decrease in plasma vitamin E level, reduction in bone mineral content and growth retardation. Ascorbic acid enhances gel formation of chitosan, thereby potentiating the plasma cholesterol lowering activity. Bile acid composition and short-chained fatty acid content in the cecum are altered by chitosan which impedes lipid emulsification and absorption. Although the increase in lipid content of feces does not appear to alter gastrointestinal functions, it may potentially aggravate the symptoms of mild steatorrhea. Chitin-chitosan inhibits in vitro growth of microorganisms including Candida and in vivo has a protective effect on Candida infection. The antibacterial and antiyeast activities of chitosan are desirable properties and may be useful in preventing infection of wounds by direct application. On prolonged ingestion, however, it may alter the normal flora of the intestinal tract which may result in the growth of resistant pathogens. Although studies with cells, on tissues and animals indicate that chitin-chitosan promotes wound healing, increases immune response, and possesses antitumor activity, these claims need to be further validated in human subjects by clinical trials. Chitin-chitosan, when used as a food supplement, does lower plasma cholesterol and triglycerides and improves the HDL-cholesterol/total cholesterol ratio. Certain medical precautions, however, should be observed with long-term ingestion of high doses of chitosan to avoid potential adverse metabolic consequences. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:1091 / 1101
页数:11
相关论文
共 47 条
[31]   EFFECT OF CHITIN AND CHITOSAN ON NUTRIENT DIGESTIBILITY AND PLASMA-LIPID CONCENTRATIONS IN BROILER-CHICKENS [J].
RAZDAN, A ;
PETTERSSON, D .
BRITISH JOURNAL OF NUTRITION, 1994, 72 (02) :277-288
[32]   Hypolipidaemic, gastrointestinal and related responses of broiler chickens to chitosans of different viscosity [J].
Razdan, A ;
Pettersson, D .
BRITISH JOURNAL OF NUTRITION, 1996, 76 (03) :387-397
[33]  
SAIKI I, 1990, CANCER RES, V50, P3631
[34]   BIOCOMPATIBILITY OF WOUND MANAGEMENT PRODUCTS - A STUDY OF THE EFFECTS OF VARIOUS POLYSACCHARIDES ON MURINE L929 FIBROBLAST PROLIFERATION AND MACROPHAGE RESPIRATORY BURST [J].
SCHMIDT, RJ ;
CHUNG, LY ;
ANDREWS, AM ;
SPYRATOU, O ;
TURNER, TD .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1993, 45 (06) :508-513
[35]   Alveolar macrophage priming by intravenous administration of chitin particles, polymers of n-acetyl-d-glucosamine, in mice [J].
Shibata, Y ;
Foster, LA ;
Metzger, WJ ;
Myrvik, QN .
INFECTION AND IMMUNITY, 1997, 65 (05) :1734-1741
[36]   Application of chitin and chitosan for biomaterials [J].
Shigemasa, Y ;
Minami, S .
BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, VOL 13, 1996, 13 :383-420
[37]  
SHIMOJOH M, 1996, P 10 S JAP SOC CHIT, V2, P90
[38]   HYPOCHOLESTEROLEMIC ACTION OF CHITOSANS WITH DIFFERENT VISCOSITY IN RATS [J].
SUGANO, M ;
WATANABE, S ;
KISHI, A ;
IZUME, M ;
OHTAKARA, A .
LIPIDS, 1988, 23 (03) :187-191
[39]   A NOVEL USE OF CHITOSAN AS A HYPOCHOLESTEROLEMIC AGENT IN RATS [J].
SUGANO, M ;
FUJIKAWA, T ;
HIRATSUJI, Y ;
NAKASHIMA, K ;
FUKUDA, N ;
HASEGAWA, Y .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1980, 33 (04) :787-793
[40]   ANTITUMOR EFFECT OF HEXA-N-ACETYLCHITOHEXAOSE AND CHITOHEXAOSE [J].
SUZUKI, K ;
MIKAMI, T ;
OKAWA, Y ;
TOKORO, A ;
SUZUKI, S ;
SUZUKI, M .
CARBOHYDRATE RESEARCH, 1986, 151 :403-408